|1.||Papich, Mark G: 5 articles (07/2014 - 11/2005)|
|2.||Elmas, Muammer: 3 articles (09/2010 - 08/2002)|
|3.||Kaartinen, L: 3 articles (05/2010 - 08/2002)|
|4.||Pyörälä, S: 3 articles (05/2010 - 08/2002)|
|5.||Martel, An: 3 articles (10/2009 - 06/2006)|
|6.||Nauwynck, Hans: 3 articles (08/2009 - 06/2006)|
|7.||Froyman, Robrecht: 3 articles (08/2009 - 06/2006)|
|8.||Duchateau, Luc: 3 articles (08/2009 - 06/2006)|
|9.||Rao, G S: 3 articles (10/2002 - 12/2000)|
|10.||Malik, J K: 3 articles (10/2002 - 12/2000)|
11/01/1992 - "Marked improvement was observed in the condition of 6 cats with opportunistic mycobacterial infections during treatment with enrofloxacin, a fluoroquinolone antibiotic. "
01/01/2014 - "Enrofloxacin was effective in protecting against supra-physiological infection. "
12/01/2011 - "Our results show that the use of enrofloxacin is effective in controlling Shigella flexneri infection in newly acquired rhesus monkeys."
08/01/2008 - "Our results show use of enrofloxacin is effective in managing Shigella infections in rhesus monkeys based upon achieving these blood drug levels."
11/01/1992 - "These findings suggested that enrofloxacin is effective in the treatment of infections caused by Mycobacterium smegmatis and M fortuitum var fortuitum in cats."
01/01/2015 - "Enrofloxacin concentrations were effective in the entire glandular tissue against the main pathogens causing mastitis in sheep. "
06/27/2015 - "The aim of this double-blinded field trial was to investigate the efficacy of enrofloxacin compared with placebo, with a special focus on survival, in dairy cows with acute clinical mastitis caused by E. "
06/27/2015 - "Efficacy of enrofloxacin for the treatment of acute clinical mastitis caused by Escherichia coli in dairy cows."
05/01/2010 - "Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis."
11/01/2000 - "coli mastitis after parturition with enrofloxacin reduced the severity of the disease, especially the decline in milk production and the changes in milk composition."
04/01/1993 - "For all dogs, profound myelosuppression developed during week 1 and pyrexia developed during week 2. Enrofloxacin was given from one day before TBI until a peripheral neutrophil count > 1.0 x 10(9)/L was achieved, which eliminated Escherichia coli from feces. "
01/01/2013 - "While side-effects associated with the collars were not noted, persistent fever necessitating enrofloxacin therapy occurred in two of the untreated cats. "
07/01/2012 - "Fever (rectal temperature, ≥ 38.5°C) after transportation was detected in 3 of 16 enrofloxacin group horses and 9 of 16 control horses; additional antimicrobial treatment was required in 2 horses in the enrofloxacin group and 7 horses in the control group. "
12/01/2015 - "The lipopolysaccharide-induced fever had no direct effect on the antibacterial activity of the enrofloxacin and alterations in PK of the drug, and its metabolite will be beneficial for its use to treat infectious diseases caused by sensitive pathogens in buffalo species. "
01/01/2012 - "Comparison of enrofloxacin and ceftiofur sodium for the treatment of relapse of undifferentiated fever/bovine respiratory disease in feedlot cattle."
|4.||Bacterial Infections (Bacterial Infection)
10/01/2002 - "It is suggested that enrofloxacin given subcutaneously may be useful in the treatment of susceptible bacterial infections in goats."
07/01/2000 - "The minimum inhibitory concentration of enrofloxacin required to inhibit 90% of isolates (MIC90) was 0.25 microg/mL for Staphylococcus aureus, Escherichia coli, Salmonella spp., Klebsiella spp., and Pasteurella spp. The poultry formulation was well tolerated and could be potentially useful in the treatment of susceptible bacterial infections in adult horses. "
03/01/2014 - "Enrofloxacin is widely used in veterinary medicine and is an important alternative to treating bacterial infections, which play an important role as causes of disease and death in captive snakes. "
02/01/2013 - "Although enrofloxacin (ENR) is widely used for therapy of bacterial infections in the veterinary clinical, bacterial resistance to ENR is becoming an increasing worldwide problem. "
08/01/1998 - "administration at 15 mg/kg. Plasma enrofloxacin concentrations were monitored during the first 3 days of treatment in five houbara bustards and kori bustards (Ardeotis kori) with bacterial infections receiving a single daily i.m. "
|5.||Body Weight (Weight, Body)
06/01/1996 - "These groups were designed to evaluate the efficacy of enrofloxacin administered orally via the drinking water or parenterally at three dosages (8.5, 25.5, and 85.0 mg/kg of body weight per day) over a 14-day treatment period. "
10/01/1990 - "Only enrofloxacin, administered in the drinking water at a concentration of 50-100 mg/l cured the rabbits, provided that a daily intake of 5 mg/kg body weight was achieved. "
06/01/1999 - "Eight adult bottlenose dolphins Tursiops truncatus (six male, two female) were employed in a single-dose study of orally administered enrofloxacin dosed at 5 mg/kg body weight. "
04/01/2011 - "The concentration values of EF detected in Tra catfish tissue were between the MRL and 2×MRL concentrations, according to the fish density, 7days following the end of the enrofloxacin treatment (20mg/kg body weight per day, for seven consecutive days). "
04/01/2010 - "The pharmacokinetic behaviour of enrofloxacin (ENRO) in plasma and nasal secretions of healthy pigs was investigated, after a single-dose intramuscular administration of 2.5 mg/kg body weight of the drug. "
|3.||Anti-Bacterial Agents (Antibiotics)
|9.||Dihydrotachysterol (AT 10)